Skip to main content


NextGen Precision Health Neuroscience Seminar – Oct. 23, 2023

The goal of the NextGen Precision Health & Neuroscience Science Seminar is to highlight transdisciplinary precision research taking place in the field, provide opportunities for collaboration among researchers to build their own research efforts and promote clinical/researcher activity across the University of Missouri System and our partners.

For questions about this event, please reach out to Veronica Lemme at

"Translational Biomarkers for Traumatic Brain Injury"

Presented by: Kevin K.W. Wang, Ph.D., Professor and Vice Chair for Research, Department of Neurobiology, Director of the Center for Neurotrauma, Multiomics & Biomarkers (CNMB), Morehouse School of Medicine, VA Research Health Scientist

Date: Oct. 23, 2023, 4-5 p.m.


Dr. Wang will discuss the discovery, validation and utilities of biofluid-based biomarkers for traumatic brain injury and how they can be used in both preclinical research and clinical research, and therapeutic development and precision medicine-based patient care. 

Speaker BioKevin K.W. Wang

Dr. Wang is professor and vice-chair for research, Department of Neurobiology, and director of the Center for Neurotrauma, Multiomics & Biomarkers (CNMB), Morehouse School of Medicine and VA Research Health Scientist (Atlanta). Dr. Wang is a neurotrauma researcher and neuroscientist since the late 1990s. From his work at the University of Florida and the biotechnology companies he co-founded (Bayan Biomarkers and Gryphon Bio), his research interest is translational research on biomarkers and new therapies for traumatic brain injury (TBI), spinal cord injury, post-traumatic epilepsy and chronic traumatic encephalopathy. Two acute TBI blood-based protein biomarkers (UCH-L1/GFAP) he co-discovered and conducted research and development on had resulted in FDA and European EMA regulatory clearance as the first in vitro diagnostic blood tests for mild TBI patients with lesions. He also holds leadership positions in the National Neurotrauma Society and TBI initiatives such as the International TBI Research Initiative (InTBIR) and multicenter TBI consortium studies (e.g. TRACK-TBI, CENTER-TBI, TOP-NT). Dr. Wang is the principal investigator of multiple research grants funded by the National Institutes of Health, Department of Defense, Veterans Affairs and other research foundations. He also has authored over 300 peer-reviewed publications and edited/co-edited six scientific books and is a co-inventor of 15 granted U.S. and international patents.